Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.

Infectious disease clinics of North America - 1 Jun 2005

Ghanem Khalil G, Giles Julie A, Zenilman Jonathan M

Abstract excerpt

The worldwide incidence of fluoroquinolone-resistant Neisseria gonorrhoeae has increased dramatically in the last few years. Single doses of fluoroquinolones can no longer be used to treat N gonorrhoeae infections acquired in the Far East, parts of the Middle East, the Pacific Islands, and parts of Western Europe and the United States. Although California and Hawaii account for most of the current United States...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Contraindications
Share to Disease Outbreaks

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Fluoroquinolones

Share to Gonorrhea

Share to Microbial Sensitivity Tests

Share to Neisseria gonorrhoeae

Source

Identifiers

PMID: 15963876
DOI: 10.1016/j.idc.2005.03.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.PMID 15963876Read ↗

<em>Neisseria gonorrhoeae</em> in the Era of Antimicrobial Resistance: From Curable STI to Clinical ChallengeSemantic proximity Read ↗

Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.Semantic proximity Read ↗

Molecular Diagnostics for Gonorrhoea: Implications for Antimicrobial Resistance and the Threat of Untreatable GonorrhoeaSemantic proximity Read ↗

Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Semantic proximity Read ↗

Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis.Semantic proximity Read ↗

Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.Semantic proximity Read ↗

Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: a genomic analysis of surveillance dataSemantic proximity Read ↗

Applications of genomics to slow the spread of multidrug‐resistant Neisseria gonorrhoeaeSemantic proximity Read ↗

Ceftriaxone-resistant<i>Neisseria gonorrhoeae</i>detected in England, 2015 to 2024; an observational studySemantic proximity Read ↗

[Unveiling Neisseria gonorrhoeae Survival: Genetic Variability, Pathogenesis, and Antimicrobial Drug Resistance].Semantic proximity Read ↗

Using genomics to understand antimicrobial resistance and transmission in Neisseria gonorrhoeaeSemantic proximity Read ↗

Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.